Add BrightSurf on Google Email

The Lancet


The Lancet research series

The Lancet research series aims to increase value and reduce waste in biomedical research by setting clear priorities, improving research design and conduct, and enhancing regulation and management. The series proposes metrics for stakeholders to monitor the implementation of recommendations.

SourceThe Lancet_DELETED·JournalThe Lancet·DateJan 8, 2014

An increase of just 2,000 steps a day cuts cardiovascular disease risk by 8 percent in those with a high risk of type 2 diabetes

A daily step increase of just 2000 steps can cut the risk of cardiovascular disease by 8% in those with a high risk of type 2 diabetes. The study, which analyzed data from 40 countries, also found that increasing physical activity levels through walking can substantially reduce the risk of heart attack and stroke.

SourceThe Lancet_DELETED·JournalThe Lancet·DateDec 19, 2013

Large differences in cancer survival between European countries still remain despite major improvements in cancer diagnosis and treatment

A recent study published in The Lancet Oncology found that cancer survival rates still differ significantly between European countries, with Nordic countries having the best survival rates for most cancers. However, there is evidence of narrowing gaps between east and west, particularly for breast and prostate cancers.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateDec 4, 2013

The British Sexual Health Survey comes of age

The study highlights that many people remain sexually active well into later life and positive sexual experiences are related to overall health and wellbeing. It also shows changes in sexual behaviour over the last century, including earlier onset of sex, increased older people's activity, and a closing gap between men and women.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 25, 2013

Primary HPV screening provides 60–70 percent greater protection against invasive cervical cancer than cytology-based screening

A study of four European trials found that HPV-based screening provided greater protection against invasive cervical cancer than cytological screening. The analysis showed that HPV-based screening protected 60-70% more women from invasive cancers, with increased protection seen in women aged 30-35 years and those screened every 5 years.

SourceThe Lancet_DELETED·JournalThe Lancet·DateNov 2, 2013

No increase in sexual risk-taking seen in partners who know they are protected from HIV transmission

A new study published in The Lancet Infectious Diseases found that HIV-negative partners who know they are protected from HIV transmission do not engage in significantly more risky sexual behavior. The researchers analyzed data from over 3,000 participants and found no increase in unprotected sex, despite knowledge of protection.

SourceThe Lancet_DELETED·JournalThe Lancet Infectious Diseases·DateOct 16, 2013

Cancer in EU cost €126 billion in 2009

The EU's total cancer cost was estimated to be €126 billion in 2009, with health care systems accounting for two-fifths of the expenditure. Lung cancer had the highest overall cost, while breast cancer was responsible for the largest share of spending on drugs.

SourceThe Lancet_DELETED·JournalThe Lancet Oncology·DateOct 13, 2013

Large meta-analysis indicates widespread use of vitamin D supplements to prevent osteoporosis in healthy adults unjustified

A large meta-analysis of 23 studies involving over 4,000 healthy adults found no significant benefit from vitamin D supplements in preventing osteoporosis. The study's authors conclude that continuing widespread use of vitamin D for osteoporosis prevention in healthy adults without specific risk factors is inappropriate.

SourceThe Lancet_DELETED·JournalThe Lancet·DateOct 10, 2013

Best-case scenario suggests that just one in five countdown countries can meet post-2015 targets for cutting child mortality rates by 2035

Even in the best-case scenario, just 15 countries are expected to meet post-2015 targets for reducing child mortality rates by 2035. The study analyzed data from 69 low- and middle-income countries and found that efforts to improve maternal and child health must intensify to achieve further substantial reductions in child deaths.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 19, 2013

Largest genetic analysis of MERS coronavirus to date suggests that virus has transmitted from animals to humans more than once

A large genetic analysis of MERS-CoV genomes suggests the virus has transmitted from animals to humans on multiple occasions. The study found that the virus evolved quickly and spread between locations, making it unlikely that a single transmission occurred. Further animal studies are needed to establish the source of the virus.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 19, 2013

New meningitis vaccine protects against epidemic strain

A new meningitis vaccine has been shown to significantly reduce the incidence of all cases of meningitis by 94% and carriage prevalence of the epidemic strain by 98%, according to a recent study. The vaccine was found to be highly effective in vaccinated regions, with no cases of serogroup A meningitis identified.

SourceThe Lancet_DELETED·JournalThe Lancet·DateSep 11, 2013